title: [Protocol for the treatment of chronic viral hepatitis].
authors.forename: Lajos
authors.initials: L
authors.lastname: Dalmi
authors.forename: Judit
authors.initials: J
authors.lastname: Gervain
authors.forename: Gábor
authors.initials: G
authors.lastname: Horváth
authors.forename: Béla
authors.initials: B
authors.lastname: Hunyady
authors.forename: Endre
authors.initials: E
authors.lastname: Ibrányi
authors.forename: Mihály
authors.initials: M
authors.lastname: Makara
authors.forename: Alajos
authors.initials: A
authors.lastname: Pár
authors.forename: Ferenc
authors.initials: F
authors.lastname: Szalay
authors.forename: István
authors.initials: I
authors.lastname: Tornai
authors.forename: László
authors.initials: L
authors.lastname: Telegdy
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D063065:Organophosphonates; D011994:Recombinant Proteins; D019259:Lamivudine; D011092:Polyethylene Glycols; D012254:Ribavirin; D007372:Interferons; D000225:Adenine; C100416:peginterferon alfa-2a; C106812:adefovir dipivoxil